Maintaining catheter patency and preventing catheter-related bloodstream infections (CRBSIs) are central goals in vascular access management. BD PosiFlush™ pre-filled syringes are uniquely designed to standardize and enhance best clinical practice for improved patient outcomes and greater clinical efficiency. New 4% sodium citrate lock solution, BD PosiFlush™ pre-filled syringes provide clinicians with the right tools to meet their clinical needs. Recommended by clinical practice guidelines as an alternative to heparin,1 4% sodium citrate provides equivalent catheter patency while offering an improved safety profile, reduction in the risk of CRBSIs and prevention of biofilm formation
- Similar antithrombotic efficacy and maintenance of catheter function vs heparin 5,000–10,000 U/mL.
- May help prevent biofilm formation
- Improve CVC dwell time
- 5ml fill
- 30 per box